Cargando…
ENPEP as a potential predictor of immune checkpoint inhibitor efficacy
BACKGROUND: The gene ENPEP encodes glutamyl aminopeptidase, which can cut N‐terminal aspartic acid from angiotensin II, and is related to tumorigenesis and immune microenvironment, however, the association between the expression of ENPEP and benefits of immune checkpoint inhibitors (ICIs) has had no...
Autores principales: | Wang, Aoyun, Chu, Han, Jin, Zheng, Gong, Zhihua, Jia, Qingzhu, Zhu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817092/ https://www.ncbi.nlm.nih.gov/pubmed/34862755 http://dx.doi.org/10.1002/cam4.4475 |
Ejemplares similares
-
Somatostatin Receptor 2: A Potential Predictive Biomarker for Immune Checkpoint Inhibitor Treatment
por: Wang, Aoyun, et al.
Publicado: (2022) -
Programmed Cell Death Protein Ligand 2 Is a Potential Biomarker That Predicts the Efficacy of Immunotherapy
por: Wang, Aoyun, et al.
Publicado: (2021) -
Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma
por: Yan, Zihao, et al.
Publicado: (2021) -
Pan‐cancer analyses reveal that increased Hedgehog activity correlates with tumor immunosuppression and resistance to immune checkpoint inhibitors
por: Jiang, Junjie, et al.
Publicado: (2021) -
Prognostic value of immune checkpoint molecules in breast cancer
por: Fang, Jun, et al.
Publicado: (2020)